Who owns EFFECTOR THERAPEUTICS INC COM?
- CUSIP Number: 28202v108
Tip: Access positions for across all investors
Analyze quarterly positions in Effector Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Effector Therapeutics stock
Who bought or sold EFFECTOR THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Carlyle | 4.8M | $2.2M | 0% | Dec 2023 |
|
| Parallel Advisors | 1.7M | $792k | 0% | Dec 2023 |
|
| Blackstone Group | 1.3M | $612k | 0% | Dec 2023 |
|
| Vanguard Group | 574k | $269k | 42% | Dec 2023 |
|
| Alyeska Investment Group | 365k | $4.3M | 100% | Dec 2023 |
|
| Two Sigma Securities | 62k | $29k | 100% | Dec 2023 |
|
| Stifel Financial | 23k | $11k | 0% | Dec 2023 |
|
| Callan Capital | 20k | $9.3k | 0% | Dec 2023 |
|
| Vontobel Holding | 15k | $7.0k | 0% | Dec 2023 |
|
| UBS Group | 9.1k | $4.2k | -8% | Dec 2023 |
|
| Simplex Trading | 1.7k | $0 | 100% | Dec 2023 |
|
| Wells Fargo & Company | 314.00 | $147.014800 | 6% | Dec 2023 |
|
| Royal Bank of Canada | 145.00 | $0 | -64% | Dec 2023 |
|
| Jpmorgan Chase & Co | 68.00 | $32.000800 | 127% | Dec 2023 |
|
| Bank of America Corporation | 27.00 | $13.000500 | 100% | Dec 2023 |
|
Who sold out of Effector Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sr One Capital Management | Sep 2023 | 6.8M | $4.0M |
| Column Group | Sep 2023 | 4.0M | $2.4M |
| Sea Otter Advisors | Sep 2023 | 264k | $158k |
| EP Wealth Advisors | Sep 2023 | 31k | $19k |
| We Are One Seven | Sep 2023 | 20k | $12k |
| Millennium Management | Sep 2023 | 14k | $8.4k |
| Barclays | Sep 2023 | 82.00 | $0 |